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Preclinical Models of
HFpEF But Without the
Intolerance?Sharp et al. (1) report a novel large animal model of
heart failure with preserved ejection fraction
(HFpEF) induced through long-term dietary and
mineralocorticoid administration, using a well-
established minipig breed with known
susceptibilities to obesity, metabolic syndrome, and
atherosclerosis. We would like to congratulate the
authors on attempting to make the complex
transition from smaller to larger pre-clinical
experimental models, an important step that is
urgently required to progress therapeutic treatments
in HFpEF. The authors concluded that their model
accurately and appropriately recapitulated all the
comorbidity complexities characteristic of the human
HFpEF condition. Curiously, however, as stated by
the authors in the introduction, all patients typically
demonstrate elevated left ventricular (LV) filling
rates, despite preserved LVEF alongside exercise
intolerance. However, it appears no data were
provided as to whether the minipigs developed signs
of exercise intolerance compared to healthy controls.
Given the sine qua non of patients with HFpEF is
exercise intolerance, one begs the question of
whether this current minipig model addresses this
important point. Exercise intolerance, characterized
by impairments to both cardiac and noncardiac
physiological reserves, is a cardinal feature of HFpEF,
as shown in the American College of Cardiology
Foundation/American Heart Association clinical
guidelines. Moreover, exercise intolerance is closely
linked to peripheral alterations in HFpEF that
includes skeletal muscle, peripheral blood flow, and
vascular abnormalities (2–5). Without data
corroborating the presence and severity of exercise
limitation, as well as secondary development of
peripheral limitations, we should pause to carefully
reflect whether this model does in fact closely reflect
the patient with HFpEF or simply reflect an almost
but not quite.Gustavo Jose Justo da Silva, PhD
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intolerance. J Am Coll Cardiol HF 2016;4:636–45.REPLY: Tolerating Large PreclinicalModels of HFpEF But Without the
Intolerance?We thank Drs. da Silva and Bowen for their comments
regarding our recent paper describing a new minis-
wine translational animal model of heart failure with
preserved ejection fraction (HFpEF). This model ex-
hibits the spectrum of multiorgan pathophysiology
characteristics of human HFpEF. We are excited that
other researchers are critically evaluating our paper
and welcome further discussions, as this can only aid
in moving the field forward in finding effective
treatments for HFpEF patients. Drs. da Silva and
Bowen are correct in their observations that our study
did not incorporate exercise tolerance, and we
wholeheartedly agree that this was a limitation of the
